Emergent stock jumps as FDA clears smallpox vaccine for people at high risk of mpox (NYSE:EBS)
Emerging Bio-Solutions (New York: EBS) stocks jumped 23% pre-market Friday The U.S. Food and Drug Administration (FDA) has approved expanded use of the company's ACAM2000 smallpox vaccine to include people at risk of smallpox infection.…
